1. Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma. Issue 1 (17th January 2023) Authors: Fan, Rong; Satilmis, Hatice; Vandewalle, Niels; Verheye, Emma; Vlummens, Philip; Maes, Anke; Muylaert, Catharina; De Bruyne, Elke; Menu, Eline; Evans, Holly; Chantry, Andrew; De Beule, Nathan; Hose, Dirk; Törngren, Marie; Eriksson, Helena; Vanderkerken, Karin; Maes, Ken; Breckpot, Karine; De Veir... Journal: Journal for immunotherapy of cancer Issue: Volume 11:Issue 1(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗